In these days of 2020, tests for the diagnosis of SARS-CoV-2, and their use in the context of health surveillance of workers, are becoming popular. Nevertheless, their sensitivity and specificity could vary on the basis of the type of test used and on the moment of infection of the subject tested. The aim of this viewpoint paper is to make employers, workers, occupational physicians, and public health specialists think about the limits of diagnostic tests currently available, and the possible implication related to the erroneous and incautious assignment of “immunity passports” or “risk-free certificates” to workers during screening campaigns in workplaces.
All Keywords
【저자키워드】 COVID-19, public health, SARS-CoV-2, occupational health, Reverse transcriptase polymerase chain reaction, Sensitivity and specificity, serologic tests, Predictive Value of Tests, 【초록키워드】 diagnostic test, Infection, Health, Surveillance, Physicians, subject, limit, tested, diagnosis of SARS-CoV-2, 【제목키워드】 negative,
【저자키워드】 COVID-19, public health, SARS-CoV-2, occupational health, Reverse transcriptase polymerase chain reaction, Sensitivity and specificity, serologic tests, Predictive Value of Tests, 【초록키워드】 diagnostic test, Infection, Health, Surveillance, Physicians, subject, limit, tested, diagnosis of SARS-CoV-2, 【제목키워드】 negative,